Evidence map›Paper›PMID 39456574›Full record

ArticleCancers2024

Development of an MRI Radiomic Machine-Learning Model to Predict Triple-Negative Breast Cancer Based on Fibroglandular Tissue of the Contralateral Unaffected Breast in Breast Cancer Patients.

Roberto Lo Gullo, Rosa Elena Ochoa-Albiztegui, Jayasree Chakraborty, Sunitha B Thakur, Mark Robson, Maxine S Jochelson, Keitha Varela, Daphne Resch, Sarah Eskreis-Winkler, Katja Pinker

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Application of Machine Learning to Breast MR Imaging.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Roberto Lo GulloDepartment of Radiology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY 10065, USA.
Rosa Elena Ochoa-AlbizteguiDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-5443-6702
Jayasree ChakrabortyDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sunitha B ThakurDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0001-8090-3696
Mark RobsonDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Maxine S JochelsonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Keitha VarelaCUNY School of Medicine, New York, NY 10031, USA.ORCID 0009-0000-7007-9226
Daphne ReschMedical School, Sigmund Freud University, A-1020 Vienna, Austria.
Sarah Eskreis-WinklerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Katja PinkerDepartment of Radiology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY 10065, USA.ORCID 0000-0002-2722-7331

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Breast Cancer Research Foundation N/ANCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

aimThe purpose of this study was to develop a radiomic-based machine-learning model to predict triple-negative breast cancer (TNBC) based on the contralateral unaffected breast's fibroglandular tissue (FGT) in breast cancer patients. MATERIALS AND

methodsThis study retrospectively included 541 patients (mean age, 51 years; range, 26-82) who underwent a screening breast MRI between November 2016 and September 2018 and who were subsequently diagnosed with biopsy-confirmed, treatment-naïve breast cancer. Patients were divided into training (

resultsIn the validation set, the final prediction model, which included four radiomic features, achieved an F1 score of 0.66, an area under the curve of 0.71, a sensitivity of 54% [47-60%], a specificity of 74% [65-84%], a positive predictive value of 84% [78-90%], and a negative predictive value of 39% [31-47%].

conclusionsTNBC can be predicted based on radiomic features extracted from the FGT of the contralateral unaffected breast of patients, suggesting the potential for risk prediction specific to TNBC.

Indexed as

breast cancerfibroglandular tissueradiomicstriple-negative breast cancer

Identifiers

PMID39456574
PMCPMC11506272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.